Literature DB >> 408478

Time-dependent kinetics III: diurnal oscillations in steady-state plasma valproic acid levels in rhesus monkeys.

R H Levy, J S Lockard, I H Patel, W C Congdon.   

Abstract

Valproic acid was administered by constant rate intravenous infusion to catheterized chained rhesus monkeys for 8-10 weeks under controlled environmental conditions. Steady-state plasma levels were monitored at 2-hr intervals for 26 hr (10 am-12 noon on the following day), 1 day/week for 6 weeks. Individual steady-state plasma concentration-time plots exhibited the following characteristics. During Period A (10 am-6 pm), plasma levels remained stable or decreased. During Period B (6 pm-6 am), plasma levels increased, reached a maximum, and remained markedly higher than during Period A. The maximum concentrations were 40-140% higher than the observed minimum concentrations. During Period C (6 am-noon), plasma levels tended to decline from the maximum concentrations achieved in Period B. In most cases, plasma concentrations at 10 am and 12 noon of the 2nd experimental day fell within 10% of their respective values on the previous day. The mean (+/- SD) periods obtained by cross-correlation analysis of individual plasma concentration-time plots were 30.7 (+/- 3.7) and 22.8 (+/- 3.6) hr for Animals 903 and 923, respectively. The corresponding mean (+/- SD) amplitudes were 27.3 (+/- 12.6) and 17.4 (+/- 2.3)%. A circadian rhythm in total body clearance was hypothesized, and its pharmacokinetic implications are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 408478     DOI: 10.1002/jps.2600660827

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

Review 1.  Time-dependence in benzodiazepine pharmacokinetics. Mechanisms and clinical significance.

Authors:  T W Guentert
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

2.  Diurnal variations in steady-state plasma concentrations of valproic acid in epileptic patients.

Authors:  P Loiseau; B Cenraud; R H Levy; R Akbaraly; A Brachet-Liermain; M Guyot; P L Morselli
Journal:  Clin Pharmacokinet       Date:  1982 Nov-Dec       Impact factor: 6.447

3.  Pharmacokinetics of free and total sodium valproate in adolescents and young adults during maintenance therapy.

Authors:  L Herngren; A Nergårdh
Journal:  J Neurol       Date:  1988-11       Impact factor: 4.849

4.  Preclinical pharmacology of the antitumor agent O-6-methylguanine in CDF1 mice.

Authors:  V I Avramis; K K Chan; M M Solorzano; Z L Chen
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.